In both the intracardiac and the intratibial injection model, the frequency of BM NK cells, GrB+ NK cells, and Th1 cells was increased by bone tumor growth in control mice but not in those treated with anti-CXCL9 antibody (Figure 11, A–C and E–G). This evidence concerns the gene CXCL9 and bone neoplasm.